CMY-2-type plasmid-mediated AmpC beta-lactamase finally emerging in Argentina.
Rapoport
M
M
Monzani
V
V
Pasteran
F
F
Morvay
L
L
Faccone
D
D
Petroni
A
A
Galas
M
M
D001118:Argentina / Q000453:epidemiology; D018550:Cephalosporin Resistance; D002513:Cephamycins / Q000494:pharmacology; D004405:Dysentery, Bacillary / Q000453:epidemiology* / Q000382:microbiology*; D004591:Electrophoresis, Polyacrylamide Gel; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics; D005798:Genes, Bacterial / Q000235:genetics; D006801:Humans; D008826:Microbial Sensitivity Tests; D010957:Plasmids / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012763:Shigella flexneri / Q000235:genetics*; D001618:beta-Lactamases / Q000235:genetics*
D002513:Cephamycins; C103022:beta-lactamase CMY-2; D001618:beta-Lactamases